These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2775849)

  • 21. Solute-induced circular dichroism: drug discrimination by cyclodextrin.
    Han SM; Atkinson WM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2827-30. PubMed ID: 6524659
    [No Abstract]   [Full Text] [Related]  

  • 22. Relative affinity of 5-methoxypsoralen and 8-methoxypsoralen towards beta-cyclodextrin: a fluorescence, circular dichroism and chromatographic study.
    Blais J; Prognon P; Mahuzier G; Vigny P
    J Photochem Photobiol B; 1988 Dec; 2(4):455-65. PubMed ID: 3150000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
    Koontz JL; Marcy JE
    J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins.
    Brewster ME; Estes KS; Bodor N
    J Parenter Sci Technol; 1989; 43(6):262-5. PubMed ID: 2600731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of cyclodextrins on anthracycline stability in acidic aqueous media.
    Bekers O; Beijnen JH; Groot Bramel EH; Otagiri M; Underberg WJ
    Pharm Weekbl Sci; 1988 Oct; 10(5):207-12. PubMed ID: 3205677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion compounds of lankacidin-group antibiotics with cyclodextrins.
    Harada S; Okada J; Takeda M; Yamazaki T
    J Antibiot (Tokyo); 1985 Jul; 38(7):877-85. PubMed ID: 4030501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inclusion complex formation of 1,8-dihydroxyanthraquinone with cyclodextrins in aqueous solution and in solid state.
    Smulevich G; Feis A; Mazzi G; Vincieri FF
    J Pharm Sci; 1988 Jun; 77(6):523-6. PubMed ID: 3171933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracking of enantioselective solubility of rac-norgestrel in the presence of cyclodextrin by a CD spectroscopic method.
    Szegvári D; Zelkó R; Horváth P; Gergely A
    Chirality; 2006 Feb; 18(2):121-6. PubMed ID: 16385617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclodextrins as solubilizers: formation of complex aggregates.
    Jansook P; Kurkov SV; Loftsson T
    J Pharm Sci; 2010 Feb; 99(2):719-29. PubMed ID: 19670293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of roll mixing with beta-cyclodextrin on enhancing solubilities of water insoluble drugs.
    Nozawa Y; Yamamoto A
    Pharm Acta Helv; 1989; 64(1):24-9. PubMed ID: 2717647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectroscopic investigation of the aggregation state of amphotericin B during loading, freeze-drying, and reconstitution of polymeric micelles.
    Adams M; Kwon GS
    J Pharm Pharm Sci; 2004 Nov; 7(4):1-6. PubMed ID: 15850542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphotericin B and monoacyl-phosphatidylcholine form a stable amorphous complex.
    Liu X; Berthelsen R; Bar-Shalom D; Kjellerup Lind T; Doutch J; Müllertz A
    Int J Pharm; 2023 Feb; 633():122601. PubMed ID: 36632922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. γ-Cyclodextrin.
    Saokham P; Loftsson T
    Int J Pharm; 2017 Jan; 516(1-2):278-292. PubMed ID: 27989822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK; Naik SR
    J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety assessment of gamma-cyclodextrin.
    Munro IC; Newberne PM; Young VR; Bär A
    Regul Toxicol Pharmacol; 2004 Jun; 39 Suppl 1():S3-13. PubMed ID: 15265610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some properties and the inclusion behavior of branched cyclodextrins.
    Okada Y; Kubota Y; Koizumi K; Hizukuri S; Ohfuji T; Ogata K
    Chem Pharm Bull (Tokyo); 1988 Jun; 36(6):2176-85. PubMed ID: 3240453
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical usefulness of hydroxypropylcyclodextrins: "e pluribus unum" is an essential feature.
    Rao CT; Fales HM; Pitha J
    Pharm Res; 1990 Jun; 7(6):612-5. PubMed ID: 2367328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.